MASSACHUSETTS GENERAL HOSPITAL
Department of Pharmacy
Department of Nursing
Pediatric General Care Guideline
DO NOT ADMINISTER AS BOLUS or RAPID IV PUSH
Generic Name: |
Phosphate; Sodium |
Trade Name: |
|
Action: |
Electrolyte replacement |
Indications: |
Hypophosphatemia |
Administration Guidelines: |
|
Usual Dosage Range and Route: |
0.08 to 0.36 mmol/kg/dose
Maximum dose 45mmol/24 hrs or 1.5 – 2 mmol/kg/24hrs, whichever is less
Dose should be based on patient's condition and serum phosphate level Note patient's serum phosphate levels vary by age
Reference MGH Values 0-9.9 days: 4.5-9.0 mg/dL Adults: 2.6-4.5 mg/dL
|
Maximum Concentrations:
|
Central: 0.12 mmol/mL Peripheral: 0.05 mmol/mL SODIUM 4mEq = PHOSPHATE 3mmol |
Rate of Administration |
Usual Rate 0.06 mmol/kg/hour, Contact pharmacy if using higher rates DO NOT EXCEED 7.5 mmol/hour |
Special Considerations: |
Monitor serum and/or ionized calcium Monitor serum phosphate 4-6 hours after infusion completed Must be infused on a mechanical infusion device Please consult your floor pharmacist for indication specific considerations |
Precautions:
|
Use with caution in patients with renal impairment Caution when repleting chronically low phosphate. May develop re-feeding syndrome (> 48 hrs NPO) if replaced too quickly (by dose or rate) |
Side Effects: |
Tetany Hypocalcemia Burning sensation if administered through peripheral access
|
|
|
|
|